LOS ANGELES CAPITAL MANAGEMENT LLC

Position in SANA — Sana Biotechnology, Inc.

CIK 1177206 LOS ANGELES, CA

Position in SANA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$674,557

+$459,056 QoQ

Shares Held

193,283

+158.3% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#48

of 211 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 20% Shared 0% None 80%

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. SANA ranks #45 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	729,635	$219,642,024
2	HALO	Halozyme Therapeutics, Inc.	1,938,035	$151,689,999
3	CAI	Caris Life Sciences, Inc.	3,958,531	$70,541,022
4	INCY	Incyte Corp	578,986	$65,633,852
5	VRTX	Vertex Pharmaceuticals Inc / Ma	130,802	$64,973,277
6	EXEL	Exelixis, Inc.	1,159,457	$63,086,055
7	REGN	Regeneron Pharmaceuticals, Inc.	98,585	$61,471,690
8	RPRX	Royalty Pharma plc	877,674	$49,211,181

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$674,557	193,283	+158.3%	Shares	Sole	2026-08-13
2026-03-31	$215,501	74,827	+4908.5%	Shares	Sole	2026-05-08
2025-12-31	$6,080	1,494	-93.6%	Shares	Sole	2026-02-11
2025-09-30	$82,395	23,210	-0.2%	Shares	Sole	2025-10-20
2025-06-30	$63,486	23,255	-66.9%	Shares	Sole	2025-08-07
2024-03-31	$702,450	70,245	-47.8%	Shares	Sole	2024-04-05
2023-12-31	$549,323	134,638	-0.8%	Shares	Sole	2024-02-06
2023-09-30	$525,085	135,681	+0.8%	Shares	Sole	2023-11-06
2023-06-30	$802,442	134,638	-2.7%	Shares	Sole	2023-08-03
2023-03-31	$452,365	138,338	-2.1%	Shares	Sole	2023-05-04
2022-12-31	$558,210	141,319	0.0%	Shares	Sole	2023-02-06
2022-09-30	$847,914	141,319	-10.3%	Shares	Sole	2022-11-02
2022-06-30	$1,012,654	157,489	-48.3%	Shares	Sole	2022-08-05
2022-03-31	$2,516,541	304,666	—	Shares	Sole	2022-05-06
No filing history on record for this holder in this stock.